We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
+5.71%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$22.7B
AUM Growth
+$2.61B
(+13%)
Cap. Flow
+$1.88B
Cap. Flow
% of AUM
8.3%
Top 10 Holdings %
Top 10 Hldgs %
32.91%
Holding
930
New
47
Increased
619
Reduced
193
Closed
47
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
B2Gold
BTG
|
+$127M |
| 2 |
Alamos Gold
AGI
|
+$111M |
| 3 |
VanEck Gold Miners ETF
GDX
|
+$78.1M |
| 4 |
B
Barrick Mining
B
|
+$71.5M |
| 5 |
GSV
Gold Standard Ventures Corp.
GSV
|
+$59.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SM Energy
SM
|
+$89.9M |
| 2 |
GPOR
Gulfport Energy Corp.
GPOR
|
+$69.6M |
| 3 |
Diamondback Energy
FANG
|
+$26.1M |
| 4 |
Invesco DB US Dollar Index Bullish Fund
UUP
|
+$20.2M |
| 5 |
MHG
Marine Harvest ASA
MHG
|
+$17.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 56.29% |
| 2 | Energy | 16.8% |
| 3 | Healthcare | 6.46% |
| 4 | Technology | 3.59% |
| 5 | Industrials | 2.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RDC
176
DELISTED
Rowan Companies Plc
RDC
| $17.7M | 0.08% |
1,137,042
+196,911
| +21% | +$3.47M |
|
177
AstraZeneca
AZN
$263B
| $17.6M | 0.08% |
282,870
+58,122
| +26% | +$3.38M |
|
178
Sanofi
SNY
$104B
| $17.4M | 0.08% |
384,526
+65,906
| +21% | +$2.8M |
|
179
Prospect Capital
PSEC
$1.06B
| $17.1M | 0.08% |
1,897,023
+415,831
| +28% | +$3.73M |
|
180
GSK
GSK
$103B
| $17.1M | 0.08% |
323,625
+48,569
| +18% | +$2.46M |
|
181
AbbVie
ABBV
$458B
| $17M | 0.07% |
260,277
+44,523
| +21% | +$2.8M |
|
182
FMC
FMC
$1.42B
| $16.9M | 0.07% |
280,134
-4,432
| -2% | -$229K |
|
183
Merck
MRK
$324B
| $16.1M | 0.07% |
265,001
+30,865
| +13% | +$1.87M |
|
|
TMUSP
184
DELISTED
T-Mobile US, Inc.5.50% Mandatory Convertible Preferred Stock, Series A
TMUSP
| $15.7M | 0.07% |
148,822
+7,358
| +5% | +$740K |
|
185
Annaly Capital Management
NLY
$16.9B
| $15.6M | 0.07% |
352,113
-33,498
| -9% | -$1.43M |
|
186
Qiagen
QGEN
$8.53B
| $15.6M | 0.07% |
+509,066
| New | +$15.7M |
|
187
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.9B
| $15.6M | 0.07% |
771,376
+10,329
| +1% | +$198K |
|
|
NVO
188
Novo Nordisk
NVO
$216B
| $15.6M | 0.07% |
908,098
+247,904
| +38% | +$4.32M |
|
|
MJN
189
DELISTED
Mead Johnson Nutrition Company
MJN
| $15.5M | 0.07% |
173,533
+24,286
| +16% | +$2M |
|
|
DO
190
DELISTED
Diamond Offshore Drilling
DO
| $15.2M | 0.07% |
909,902
+82,353
| +10% | +$1.4M |
|
191
Ternium
TX
$9.29B
| $15.1M | 0.07% |
579,464
+228,250
| +65% | +$5.67M |
|
192
Perrigo
PRGO
$1.4B
| $15M | 0.07% |
226,227
+106,778
| +89% | +$8.12M |
|
193
Teva Pharmaceuticals
TEVA
$35.9B
| $15M | 0.07% |
466,886
+129,691
| +38% | +$4.43M |
|
194
Sunrun
RUN
$2.37B
| $15M | 0.07% |
2,768,636
-107,235
| -4% | -$597K |
|
|
VEDL
195
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
| $14.9M | 0.07% |
865,917
+212,444
| +33% | +$3.21M |
|
|
SHPG
196
DELISTED
Shire pic
SHPG
| $14.7M | 0.06% |
84,127
+13,620
| +19% | +$2.38M |
|
197
Toro Company
TTC
$8.93B
| $14.7M | 0.06% |
234,616
-10,379
| -4% | -$619K |
|
198
Vale
VALE
$62.9B
| $14.4M | 0.06% |
1,520,646
-1,462,839
| -49% | -$14.6M |
|
199
Oil States International
OIS
$522M
| $14.1M | 0.06% |
423,888
+53,571
| +14% | +$1.97M |
|
200
Viatris
VTRS
$20.1B
| $13.7M | 0.06% |
351,659
+68,866
| +24% | +$2.78M |
|
Similar funds
DAM
VanEck Associates's Q1 2017 Portfolio in Review
As of Q1 2017, VanEck Associates held 930 positions worth $22.7B, up 13% from $20.1B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
VanEck Associates deployed $1.88B of net new capital in Q1 2017, opening 47 new positions and adding to 619 existing holdings. Its largest new stake was Gold Standard Ventures Corp.: 23,596,878 shares worth $51M.
By sector, the portfolio is most concentrated in Materials at 56% of assets, up from 54% a quarter earlier, followed by Energy and Healthcare.
On the sell side, the largest reduction was SM Energy, an estimated $89.9M trimmed.
- VanEck Associates's largest Q1 2017 buy was Gold Standard Ventures Corp.: 23,596,878 shares worth $51M.
- VanEck Associates added most to B2Gold in Q1 2017, an estimated $127M increase.
- VanEck Associates's biggest Q1 2017 reduction was SM Energy, cutting an estimated $89.9M.
- VanEck Associates fully exited Invesco DB US Dollar Index Bullish Fund in Q1 2017, selling an estimated $20.2M.
- VanEck Associates's ten largest holdings make up 33% of its $22.7B portfolio in Q1 2017.
- VanEck Associates opened 47 new positions and closed 47 in Q1 2017.
- VanEck Associates's portfolio value rose 13% quarter-over-quarter to $22.7B.
Based on VanEck Associates's 13F filing for Q1 2017, filed 11 May 2017.